Intellectual Property India Publishes Patent Application for 'A Formulation Comprising A Homogeneous Population Of Mesenchymal Stem Cells And Implementations Thereof' Filed by Regrow Biosciences Private Limited

MUMBAI, India, Oct. 24 -- Intellectual Property India has published a patent application (202421031909 A) filed by Regrow Biosciences Private Limited, Pune, Maharashtra, on April 22, 2024, for 'a formulation comprising a homogeneous population of mesenchymal stem cells and implementations thereof.'

Inventor(s) include Sanghavi, Satyen; and Kedage, Vinayak.

The application for the patent was published on Oct. 24, under issue no. 43/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a formulation comprising: a) a population of mesenchymal stem cells (MSCs); and b) a carrier selected from serelaxin, Ringer's lactate solution, human serum albumin (HSA), dextran, heparin, hyaluronid...